Press "Enter" to skip to content

New patent for Astrazeneca Pharms drug LYNPARZA

2
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug LYNPARZA

Annual Drug Patent Expirations for LYNPARZA
Annual Drug Patent Expirations for LYNPARZA

Lynparza is a drug marketed by Astrazeneca Pharms and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug.

This drug has two hundred and fifty-two patent family members in fifty countries.

The generic ingredient in LYNPARZA is olaparib. One supplier is listed for this compound. Additional details are available on the olaparib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug LYNPARZA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions